Medical Charities Desert Mar-a-Lago

Breast cancer organization Susan G. Komen is the seventh organization this week to cancel plans to use the venue for fundraising events.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share


WIKIMEDIA, LIBRARY OF CONGRESS, PRINTS AND PHOTOGRAPHS DIVISION, FL-195-5

Four major organizations have today (August 18) cancelled plans to hold large fundraising events at Donald Trump’s Mar-a-Lago Club, adding to snowballing fallout from the president’s controversial comments about events in Charlottesville, Virginia, over the weekend. The organizations, which include the American Red Cross and breast cancer organization Susan G. Komen, join three others that made similar moves to distance themselves from Trump’s Palm Beach resort earlier this week.

“Our values and commitment to diversity are critical as we work to address the impact of cancer in every community,” American Cancer Society spokeswoman Miriam Falco said in statement on Thursday, as the organization announced its decision to find an alternative venue for its 2018 annual fundraiser, the Associated Press reports. “It has become increasingly clear ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Catherine Offord

    Catherine is a science journalist based in Barcelona.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours